Hookipa Pharma Correlations

HOOK Stock

USD 4.05 0.05 1.22%

The current 90-days correlation between Hookipa Pharma and Mereo BioPharma Group is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hookipa Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hookipa Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Hookipa Pharma Correlation With Market

Very weak diversification

The correlation between Hookipa Pharma and DJI is 0.54 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Moving together with Hookipa Stock

0.69	EBS	Emergent Biosolutions	Pair Corr
0.73	EVO	Evotec SE ADR	Pair Corr
0.74	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	MOLN	Molecular Partners	Pair Corr
0.62	NBIX	Neurocrine Biosciences	Pair Corr
0.8	PASG	Passage Bio	Pair Corr
0.63	PCRX	Pacira BioSciences,	Pair Corr
0.81	PEPG	PepGen	Pair Corr
0.64	PRLD	Prelude Therapeutics	Pair Corr
0.75	AEON	AEON Biopharma,	Pair Corr
0.66	ANIP	ANI Pharmaceuticals	Pair Corr
0.76	ANTX	AN2 Therapeutics	Pair Corr
0.76	STTK	Shattuck Labs	Pair Corr
0.67	BDTX	Black Diamond Therap	Pair Corr

Moving against Hookipa Stock

0.72	BMY	Bristol Myers Squibb	Pair Corr
0.69	ZTS	Zoetis Inc	Pair Corr
0.64	GILD	Gilead Sciences	Pair Corr
0.52	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.48	PAHC	Phibro Animal Health	Pair Corr
0.46	FHTX	Foghorn Therapeutics	Pair Corr
0.74	PETQ	PetIQ Inc	Pair Corr
0.73	ICUI	ICU Medical	Pair Corr
0.73	MMSI	Merit Medical Systems	Pair Corr
0.67	ABBV	AbbVie Inc	Pair Corr
0.66	COLL	Collegium Pharmaceutical	Pair Corr
0.61	NUTX	Nutex Health	Pair Corr
0.34	SUPN	Supernus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	MREO	TERN	PDSB	INZY	DAWN	ELDN	XFOR	ABOS	AMLX
MREO		0.33	-0.16	0.5	-0.06	0.27	0.25	-0.02	0.34	MREO
TERN	0.33		0.25	0.67	0.46	-0.09	0.37	0.05	0.56	TERN
PDSB	-0.16	0.25		0.31	0.71	0.27	0.47	0.53	-0.02	PDSB
INZY	0.5	0.67	0.31		0.53	0.38	0.7	0.45	0.29	INZY
DAWN	-0.06	0.46	0.71	0.53		0.34	0.64	0.53	-0.13	DAWN
ELDN	0.27	-0.09	0.27	0.38	0.34		0.72	0.81	-0.41	ELDN
XFOR	0.25	0.37	0.47	0.7	0.64	0.72		0.82	-0.12	XFOR
ABOS	-0.02	0.05	0.53	0.45	0.53	0.81	0.82		-0.44	ABOS
AMLX	0.34	0.56	-0.02	0.29	-0.13	-0.41	-0.12	-0.44		AMLX
	MREO	TERN	PDSB	INZY	DAWN	ELDN	XFOR	ABOS	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ABOS	+ 0.82	XFOR
ABOS	+ 0.81	ELDN
XFOR	+ 0.72	ELDN
DAWN	+ 0.71	PDSB
XFOR	+ 0.7	INZY
INZY	+ 0.67	TERN

High negative correlations

AMLX	- 0.44	ABOS
AMLX	- 0.41	ELDN
PDSB	- 0.16	MREO
AMLX	- 0.13	DAWN
AMLX	- 0.12	XFOR
ELDN	- 0.09	TERN

Risk-Adjusted Indicators

There is a big difference between Hookipa Stock performing well and Hookipa Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hookipa Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MREO	2.71	0.36	0.09	0.80	3.35	(3.06)	6.13	(4.89)	19.32
TERN	4.30	0.29	0.08	0.31	4.17	(5.51)	11.63	(7.55)	34.09
PDSB	3.45	0.21	0.07	0.22	3.75	(4.21)	8.46	(6.31)	21.10
INZY	2.55	(0.03)	0.04	0.10	3.44	(2.82)	6.11	(7.32)	18.79
DAWN	2.25	(0.04)	0.00	0.07	2.56	(2.43)	4.39	(4.18)	13.74
ELDN	2.51	0.08	0.01	0.23	2.41	(3.34)	6.85	(3.77)	19.36
XFOR	3.33	0.00	0.03	0.11	4.44	(3.69)	6.06	(7.04)	24.71
ABOS	4.01	(0.26)	0.00	0.03	4.22	(5.03)	9.91	(7.43)	24.99
AMLX	3.94	0.82	0.23	0.62	3.12	(5.27)	9.26	(5.56)	35.62

Hookipa Pharma Corporate Management

Lukas Flatz	CoFounder	Profile
Klaus Orlinger	Chief Officer	Profile
Reinhard Kandera	CFO Director	Profile
Matthew Beck	Executive Relations	Profile
Mark Winderlich	Chief Officer	Profile
Joern Aldag	CEO Director	Profile
Marine Popoff	Communications Mang	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC